HIGHLIGHTS
- who: Françoise Derouane and colleagues from the Department of Medical, II Institute, Cliniques Universitaires Saint-Luc have published the paper: Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine, in the Journal: (JOURNAL)
- what: Achieving pCR is therefore one of the main objectives of NAC but occurs only in a minority of patients, with 30-50% of pCR in TNBC, 50-80% in HER2-positive breast cancer and 5-20% in high-grade luminal cancers. This study demonstrated that tumors with a size > 5 cm have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.